Table 3. Meta-analysis evaluating the associations between survivin expression and clinicopathological variables.
| Clinicopathological variable | No. of | Cases | Pooled data (fixed) | Heterogeneity test | ||||
|---|---|---|---|---|---|---|---|---|
| studies | OR | 95% CI | P value | Chi2 | P value | I2(%) | ||
| Lymph node status | 8 | 505 | 0.679 | 0.509–0.905 | 0.008 | 1.63 | 0.977 | 0.00% |
| FIGO stage | 9 | 533 | 0.843 | 0.626–1.137 | 0.264 | 2.28 | 0.971 | 0.00% |
| Tumor grade | 10 | 568 | 0.913 | 0.689–1.210 | 0.527 | 3.13 | 0.959 | 0.00% |
| Tumor size | 2 | 99 | 0.825 | 0.434–1.570 | 0.559 | 0.47 | 0.494 | 0.00% |
| Stromal involvement | 3 | 264 | 0.82 | 0.545–1.233 | 0.34 | 0.49 | 0.783 | 0.00% |